Clinical trials are on for what is
being touted as the next big thing in the very lucrative sexual aid market.
This product is expected to help those women who suffer from the inability of
reaching an orgasm during sex and or have low level of arousal. This treatment
is testosterone based and the makers claim that it will trigger an increase in
the brain for sexual desire and improve blood flow to the sexual organs which
will lead to them attaining an orgasm.
The trials are currently being held
in Australia under the supervision of professors from Monash University in
Australia. Now Anorgasmia (the medical term for the inability to reach an
orgasm) is a much more common problem for women than what people think, with
almost 30% of women suffering from this condition.
It can be a very frustrating problem
for both the partners but especially for the female. And this product if it is
safe and actually does what its makers claim it will undoubtedly be a big
relief for a lot of women out there and will help them to enjoy their sex life
that much more.
However how effective this drug is
and what are the short term and long term side effects (if any) will only be
known after the trials are completed and the regulatory bodies like FDA ( Food
and Drug Administration) etc. will be definitely be keeping a keen eye on the
proceedings.
The one thing that needs to kept in
mind is that in a lot of cases anorgasmia is caused not only by physical
factors but also emotional ones as well and care needs to be taken to get these
addressed by a qualified professional. Admittedly this takes more time but in
the long run is a better solution and of a more permanent nature. Of course
therapy along with the appropriate drugs will make the process much faster and
more tangible.
So there is cause for cautious
optimism for women who want to get rid of this problem but I suggest that if
you suffer from this problem then you should consult with a good sexual
therapist to get started on resolving the problem and not wait for a wonder
drug which in any case is still a long way off before it hits the market.
No comments:
Post a Comment